Newcells head to Boston - Newcells

Retinal platform

An in vitro, light responsive, retinal model for accurate predictions of in vivo outcomes you can have confidence in.


Kidney platform

The most advanced near-physiological high throughput kidney proximal tubule cells (PTC) model to investigate drug transport modalities in vitro.

Lung epithelia model

Lung model

A model to investigate airway physiology, viral infection, drug safety and environmental impacts on lung airway epithelia.

Sinusoid iPSC-derived Liver model

Liver model

We are developing a model of liver sinusoid derived from human induced pluripotent stem cells (iPSC).

Published 19th November 2018 | Uncategorised

Newcells head to Boston

International Trade Mission  December 2018 

Newcells Biotech CEO, Dr Mike Nicholds, and CSO, Prof Lyle Armstrong, are delighted to be taking part in a global trade mission hosted by the Department for International Trade and partially funded by the Northern Powerhouse. Dr Nicholds and Prof Armstrong will travel to Greater Boston, which is the home to almost 1,000 drug discovery biotechnology companies, ranging from small start-ups to billion-dollar pharmaceutical companies, all looking to bring new innovative products to market.   

During the trade mission, they will be connecting with representatives from pharmaceutical and biotech companies interested in in-vitro assays for pre-clinical testing of new drugs or collaborating with Newcells on new assay developments. The pair will also be looking to meet with potential US-based partners to expand Newcells Biotech’s reach in North America.  

The mission will focus on the many opportunities Boston has to offer, while taking a closer look at: 

Boston’s thriving information technology, education, life sciences, energy and research & development mega-hub

Industry and innovation leaders

Investment opportunities and strategic partnerships


If you are interested in the work Newcells Biotech does and want to arrange a meeting prior to the trade mission,
please contact us on 0333 344 6291.  


Share This:
Tweet Post Share